Bioo, Jungwoo Partner on Cancer MDx Technologies | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bioo Scientific and Jungwoo F&B are partnering in an effort to improve methods of cancer diagnosis and treatment, the Austin, Texas-based company said on Monday.

As part of the collaboration Bioo will develop kits for use on Jungwoo's Image Oriented Navigation Laser Microdissection Device imaging platform. Bioo will also develop kits for global microRNA profiling and for protein extraction for peptide analysis of tumor samples using mass spectrometry.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.